RESEARCH RESULTS FOR FF-10832\, A NOVEL LIPOSOME DRUG CANDIDATE FOR IMPROVEMENT OF PHARMACOLOGICAL EFFICACY THROUGH SELECTIVE DELIVERY OF ANTI-CANCER AGENT TO TUMORS